Star Therapeutics · 2 months ago
Senior Clinical Scientist / AD, Clinical Science (Contractor)
Star Therapeutics is a Phase 3 clinical stage biotechnology company focused on developing innovative antibody therapies for serious diseases. They are seeking a Senior Clinical Scientist / Associate Director to support clinical science deliverables, including study design, data analysis, and regulatory filings, while also potentially serving as a Medical Monitor for clinical studies.
Health CareMedicalTherapeutics
Responsibilities
Develop and/or contribute to key documents to support the components of trial execution and regulatory submissions (e.g., IND Annual Reports, Investigator Brochures, Briefing Books, and Pediatric Plans)
Develop scientific rationale for methods, design, and implementation of clinical protocols, data collection systems, and final reports
Act as the scientific subject matter expert and primary contact for the assigned clinical study; take a proactive approach to identifying issues and mitigating risk
Conduct periodic review of protocol deviations in collaboration with the Clinical Operations Study Lead or designee
Perform clinical/medical data review, including safety monitoring and activities and procedures that ensure patient safety, data quality, and appropriate interpretation for assigned study/studies
Lead and participate in operational excellence projects and audit readiness activities, as appropriate
Initiate and provide scientific content and insight for development and review of: protocols, protocol amendments; ICFs; CRFs; statistical tables and listings including accurate AE (MedDRA) and concomitant medications (WHODrug) coding; audit reports; clinical study reports; inspection readiness activities, regulatory submissions; and other key study deliverables
Contribute to and review Clinical Study Report (CSR) writing (review final tables, listings, and figures; work with medical writer to review & revise CSR document; draft discussion and conclusions; and participate in comment resolution meetings)
Support the design, update, and implementation of Clinical Development Plans (CDPs) and work with functional leadership to ensure progress is in line with current plans and timelines
Collaborate with translational research on biomarker selection and data interpretation, design of non-clinical experiments, and analysis of subject samples to support clinical efficacy and safety evaluation
Stay up to date with advances in the rare blood disorders literature, including mechanism of action, diagnostic tests, standard of care treatments, drug development trends, and regulatory requirements
Assist with content development and attend and present at Investigator Meetings and other internal and external stakeholder meetings, as needed
Present study updates and topline results to Clinical Development leadership, as needed
Performs other related duties as assigned
Qualification
Required
Advanced science/health degree, such as PhD, PharmD, MSN
At the Sr Clinical Scientist level – the position requires at least 5 years of experience within Clinical Science, preferably in late-stage clinical development programs
At the AD, Clinical Scientist level, the position requires 6-8 years of experience, preferably in late-stage clinical development programs
Ability to navigate EDC and laboratory database systems to review data
Proficient in clinical research regulatory requirements (e.g., GCP and ICH)
Proficient with Microsoft Word, Excel, and PowerPoint
Ability to write clearly and concisely
Ability to present with clarity and compellingly
Detail-oriented
20% - 25% travel required
Preferred
Prior successful IND/CTA and/or NDA/BLA/MAA submission preferred
Experience supporting and participating in regulatory inspections desired
Company
Star Therapeutics
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Funding
Current Stage
Late StageTotal Funding
$315MKey Investors
Sofinnova Investments
2025-09-30Series D· $125M
2023-09-05Series C· $90M
2022-02-16Series Unknown· $100M
Leadership Team
Recent News
2025-12-11
Company data provided by crunchbase